Complete and incomplete momentum transfer components in theSinat(16O,X) reaction at 96.4, 112.4, and 127.8 MeV

Autor: R.C. Kline, Mitchell Sv, L.C. Dennis, K. W. Kemper, Zingarelli Ra, Tiede Ma

Publikováno v: Physical Review C. 48:651-661

Angular distributions and inclusive energy spectra of isotopes with masses 23--41 were measured for the reaction [sup nat]Si([sup 16]O,[ital X]) at bombarding energies of 96.4, 112.4, and 127.8 MeV. Complete and incomplete projectile momentum transfe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a79f41cb14b98aace4539e2439b6fdb8
https://doi.org/10.1103/physrevc.48.651

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Microfluidic Chip Enables Isolation of Exosomes and Establishment of Their Protein Profiles and Associated Signaling Pathways in Ovarian Cancer.

Autor: Dorayappan KDP; Division of Gynecologic Oncology, Department of Obstetrics/Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio., Gardner ML; Department of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Wexner Medical Center, Columbus, Ohio., Hisey CL; Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio., Zingarelli RA; Division of Gynecologic Oncology, Department of Obstetrics/Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio., Smith BQ; Division of Gynecologic Oncology, Department of Obstetrics/Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio., Lightfoot MDS; Division of Gynecologic Oncology, Department of Obstetrics/Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio., Gogna R; Champalimaud Center for the Unknown, Lisbon, Portugal., Flannery MM; Division of Gynecologic Oncology, Department of Obstetrics/Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio., Hays J; Division of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio., Hansford DJ; Department of Biomedical Engineering, The Ohio State University, Columbus, Ohio., Freitas MA; Department of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Wexner Medical Center, Columbus, Ohio., Yu L; Department of Biostatistics, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio., Cohn DE; Division of Gynecologic Oncology, Department of Obstetrics/Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio., Selvendiran K; Division of Gynecologic Oncology, Department of Obstetrics/Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio. karuppaiyah.1@osu.edu.

Publikováno v: Cancer research [Cancer Res] 2019 Jul 01; Vol. 79 (13), pp. 3503-3513. Date of Electronic Publication: 2019 May 16.

High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer.

Autor: Wallbillich JJ; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Josyula S; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Saini U; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Zingarelli RA; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Dorayappan KD; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Riley MK; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Wanner RA; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Cohn DE; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America., Selvendiran K; Division of Gynecologic Oncology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.

Publikováno v: PloS one [PLoS One] 2017 Jan 23; Vol. 12 (1), pp. e0170318. Date of Electronic Publication: 2017 Jan 23 (Print Publication: 2017).